Eligibility Requirements When BCBS plans do cover Wegovy, coverage is generally based on meeting the following criteria: Obesity (BMI of 30 or higher) Overweight (BMI of 27 or higher) with at least one weight-related medical condition, such as hypertension, high cholesterol, or type 2 diabetes Coverage may also be available for other FDA-approved indications, including cardiovascular risk reduction and MASH treatment
FIGURE 6 Recommendation: In CF, evidence supports both symptomatic and disease-modifying benefits, particularly in preventing biofilm formation and preserving lung function
The peptide mice were reported to have experienced considerable weight loss, suggesting that the peptide may not depend on the lipolytic receptors to exert any action
A GLP-1 agonist mimics the actions of GLP-1, promoting insulin release and lowering blood sugar levels
For pharma IP teams and institutional investors, PBM regulatory risk is no longer a distant policy question it is a near-term variable in drug pricing models, biosimilar access timelines, and specialty pharmacy revenue projections
